Cboe UK CHF

Basilea Pharmaceutica AG (BSLNZ.XC)

Compare
41.05 -0.40 (-0.97%)
At close: 4:19:51 PM GMT
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
14,245.00
14,245.00
7,056.00
-32,020.00
-54,134.00
Investing Cash Flow
-1,034.00
-1,034.00
91,649.00
3,575.00
-34,963.00
Financing Cash Flow
-57,305.00
-57,305.00
-45,246.00
16,640.00
45,067.00
End Cash Position
64,322.00
64,322.00
108,567.00
54,953.00
66,256.00
Capital Expenditure
-1,034.00
-1,034.00
-3,303.00
-860.00
-2,265.00
Issuance of Capital Stock
2,390.00
2,390.00
4,426.00
44,106.00
4,809.00
Issuance of Debt
--
--
73,875.00
--
97,085.00
Repayment of Debt
-59,314.00
-59,314.00
--
-23,212.00
-53,634.00
Repurchase of Capital Stock
-381.00
-381.00
--
-4,254.00
--
Free Cash Flow
13,211.00
13,211.00
3,753.00
-32,880.00
-56,399.00
12/31/2020 - 11/24/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade